“The final crossing of t’s and dotting of i’s – and what should be my last update on SEC v Ripple ever… Last week, the SEC agreed to drop its appeal without conditions. Ripple has now ...

Ripple on Tuesday said that it's agreed to buy ... including hedge funds. The acquisition marks one of the largest deals in the digital asset space to date, topping Stripe's $1.1 billion February ...

Through this acquisition, Ripple will greatly expand the reach of its flagship stablecoin, Ripple USD (RLUSD). The token will now be used as collateral across Hidden Road’s brokerage products. The ...

Long-term investors in Ripple (CRYPTO: XRP) are likely very pleased. Over the past 10 years, XRP's value has exploded 21,600% higher. Most of Ripple's value, however, has been created in short bursts.

Marks agreed to give Kennedy's associates the ability to read thousands of reports of potential vaccine-related issues sent to the government's Vaccine Adverse Event Reporting System, or VAERS.

UPDATE: The headline has been updated to reflect Ripple’s clarification the “bad actor” designation was not applied as part of its settlement with the SEC. Ripple has emerged (mostly ...

TSPSC Group 1 Marks 2025: The Telangana Public Service Commission (TSPSC) has released Group 1 mains examinations marks. Those who took the exam can check the marks and General Ranking List (GRL) at ...

Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, resigns after being pressured by HHS Secretary RFK Jr. Marks criticized Kennedy for promoting vaccine ...

Dr. Peter Marks, a veteran of the agency, wrote that undermining confidence in vaccines is irresponsible and a danger to public health. By Christina Jewett Sheryl Gay Stolberg and Noah Weiland The ...

Dr. Peter Marks, who oversaw the FDA’s vaccine division as director of the Center for Biologics Evaluation and Research, submitted his resignation to acting FDA Commissioner Sara Brenner on Friday.